Financhill
Back

ePlus Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Buy
59

PLUS
ePlus

Last Price:
$82.19
Seasonality Move:
0.19%
Sell
10

CRNX
Crinetics Pharmaceuticals

Last Price:
$38.82
Seasonality Move:
-1.28%
Buy
59
ePlus (PLUS) is a Buy

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.06. The Score for PLUS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • PLUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
10
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $37.35. The Score for CRNX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $37.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 61.25 Buy
Chaikin Money Flow: -72535 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.65 - 78.37) Buy
Bollinger Bands (100): (78.44 - 97.2) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.86 Sell
Relative Strength Index (14 RSI): 24.86 Sell
Chaikin Money Flow: -35896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.32 - 56.24) Sell
Bollinger Bands (100): (48.55 - 58.57) Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.73 Buy
20-day SMA: 75.45 Buy
50-day SMA: 80.23 Sell
200-day SMA: 83.64 Sell
8-day EMA: 78.14 Buy
20-day EMA: 77.24 Buy
50-day EMA: 80.28 Sell
200-day EMA: 82.21 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.46 Sell
20-day SMA: 47.63 Sell
50-day SMA: 53.38 Sell
200-day SMA: 50.82 Sell
8-day EMA: 40.25 Sell
20-day EMA: 45.8 Sell
50-day EMA: 50.67 Sell
200-day EMA: 49.24 Sell

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.53 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):